News

ABK Biomedical, an Innovacorp portfolio company, has announced FDA 510(k) clearance of Easi-Vue embolic microspheres for the treatment of patients suffering from arteriovenous malformations and hypervascular tumors. Read ABK's press release.

September 12, 2022, Halifax, Nova Scotia